Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amber International Holding, primarily operating through its brand Amber Life Sciences, is a global pharmaceutical and life sciences organization specializing in manufacturing, distribution, and clinical services. The company provides a comprehensive suite of solutions including contract manufacturing (CMO) for generics and specialty drugs, regulatory affairs consultancy, and international supply chain management. With a significant presence in emerging markets such as the CIS region, Africa, and Southeast Asia, Amber International Holding facilitates the global reach of healthcare products while maintaining compliance with international quality standards like WHO-GMP. The group serves as a strategic partner for biotech and pharmaceutical companies looking to navigate complex regulatory landscapes and expand their commercial footprint globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amber International Holding.